Loading...
•
Sep 30, 2022
Teladoc Q3 2022 Earnings Report
Teladoc Health's third quarter results reflected revenue growth and adjusted EBITDA exceeding expectations.
Key Takeaways
Teladoc Health reported a 17% increase in revenue, reaching $611.4 million. The net loss was $73.5 million, or $0.45 per share. Adjusted EBITDA totaled $51.2 million. Cash flow from operating activities was $63.0 million for the quarter.
Third quarter revenue grew 17% year-over-year to $611.4 million.
Net loss totaled $73.5 million, or $0.45 per share.
Adjusted EBITDA totaled $51.2 million.
Cash flow from operating activities was $63.0 million for the quarter.
Revenue by Geographic Location
Forward Guidance
Teladoc Health provided its outlook for the fourth quarter and full year 2022, based on current market conditions and expectations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...